Welcome to our dedicated page for VTEX SEC filings (Ticker: VTEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how VTEX converts rising gross merchandise volume into subscription revenue isn鈥檛 simple鈥攖he company files under IFRS, mixes 20-F language with U.S. Form 4s, and discloses fast-moving international contracts. If you have ever searched for 鈥淰TEX SEC filings explained simply,鈥� you already know the challenge.
Stock Titan turns that complexity into clarity. Our AI reads each 20-F, 6-K, 8-K, and proxy statement the moment it hits EDGAR, then delivers plain-English highlights鈥攏o jargon. Need to monitor VTEX insider trading Form 4 transactions or get a VTEX quarterly earnings report 10-Q filing equivalent from the latest 6-K? You鈥檒l receive side-by-side metrics, trend graphs, and risk flags in seconds. AG真人官方-time alerts cover every VTEX Form 4 insider transactions real-time, while concise summaries answer common queries such as 鈥渦nderstanding VTEX SEC documents with AI.鈥�
Investors use these insights to:
- Spot founder and VTEX executive stock transactions Form 4 before price moves
- Compare regions and verticals with our VTEX earnings report filing analysis
- Review key pay packages via the latest VTEX proxy statement executive compensation
- See how new contracts appear in VTEX 8-K material events explained
- Digest the VTEX annual report 10-K simplified (20-F) without reading 200 pages
Whether you鈥檙e following margin trends or checking covenant compliance, Stock Titan鈥檚 AI-powered summaries, expert context, and real-time feeds let you act on VTEX disclosures the moment they鈥檙e filed.
VTEX Form 144 summary reports a proposed sale of 65,489 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $282,257.59. The securities were acquired as Restricted Stock Units from the issuer on 10/25/2021 and the planned approximate sale date is shown as 08/11/2025 on the NYSE.
The filing also lists 14 prior trades executed under a 10b5-1 plan between 05/12/2025 and 08/06/2025, totaling 104,426 shares sold, and shows 103,947,244 shares outstanding. The filer certifies they do not possess undisclosed material adverse information at the plan adoption or instruction date.
VTEX filed a Form 144 notifying the market of a proposed sale of 65,489 common shares with an aggregate market value of $282,257.59. The sale is scheduled to occur on 08/11/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The filing shows these shares were originally acquired as founders shares on 10/25/2019 and reports the issuer has 103,947,244 shares outstanding, making this a disclosure of an insider sale.
The Form also lists multiple recent 10b5-1 sales by "SIGNO INV TECH CO LTD" between May and August 2025 (including sales of 100; 6,250; and several 8,173-share transactions), indicating ongoing plan-based dispositions. The filing does not provide a date for adoption of any 10b5-1 plan or a stated reason for the proposed sale.
FAQ
What is the current stock price of VTEX (VTEX)?
What is the market cap of VTEX (VTEX)?
